Rosetta Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '17 Jun 30, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Revenue	2.86	2.04	2.88	1.33	0.41	0.2
Revenue Growth (YoY)	106.43%	-29.08%	116.65%	227.65%	101.49%	95.15%
Cost of Revenue	1.9	1.54	1	1.31	0.71	0.26
Gross Profit	0.96	0.5	1.87	0.02	-0.3	-0.06
Selling, General & Admin	8.67	9.98	12.02	12.34	11.3	6.96
Research & Development	2.89	3.16	2.96	1.93	1.74	1.25
Operating Expenses	11.56	13.13	14.97	14.27	13.04	8.21
Operating Income	-10.59	-12.64	-13.1	-14.25	-13.35	-8.27
Interest Expense	-0.69	-0.6	-0.59	-0.04	-0.02	-1.84
Interest & Investment Income	0.01	0.01	0.05	0.11	0.15	0.04
Currency Exchange Gain (Loss)	0.01	-0.01	0.01	-0.41	-0.01	0.03
Other Non Operating Income (Expenses)	1.73	0.01	-1.05	0.08	0.06	-0.67
EBT Excluding Unusual Items	-9.53	-13.22	-14.68	-14.51	-13.17	-10.7
Impairment of Goodwill	-	-	0.16	-	-	-
Pretax Income	-9.53	-13.22	-14.53	-14.51	-13.17	-10.7
Income Tax Expense	-0.05	-0.03	0.02	0.02	-	-
Earnings From Continuing Operations	-9.48	-13.18	-14.55	-14.53	-13.17	-10.7
Earnings From Discontinued Operations	-3.91	-3.05	-2.8	-	0.27	0.24
Net Income	-13.39	-16.23	-17.35	-14.53	-12.9	-10.46
Net Income to Common	-13.39	-16.23	-17.35	-14.53	-12.9	-10.46
Shares Outstanding (Basic)	2	2	1	1	1	0
Shares Outstanding (Diluted)	2	2	1	1	1	0
Shares Change (YoY)	34.34%	46.51%	34.28%	17.16%	115.67%	776.33%
EPS (Basic)	-6.41	-8.81	-13.79	-15.51	-16.13	-28.21
EPS (Diluted)	-6.41	-8.81	-13.79	-15.51	-16.13	-28.21
Free Cash Flow	-11.73	-10.7	-17.05	-13.85	-11.23	-8.91
Free Cash Flow Per Share	-5.61	-5.81	-13.56	-14.79	-14.05	-24.03
Gross Margin	33.65%	24.42%	65.11%	1.28%	-75.06%	-28.36%
Operating Margin	-370.55%	-619.67%	-455.62%	-1074.00%	-3295.56%	-4112.94%
Profit Margin	-468.35%	-796.13%	-603.30%	-1094.65%	-3184.44%	-5202.49%
Free Cash Flow Margin	-410.21%	-524.96%	-593.04%	-1043.63%	-2773.83%	-4431.34%
EBITDA	-10.35	-12.37	-12.8	-13.95	-13.05	-7.99
D&A For EBITDA	0.24	0.27	0.3	0.3	0.3	0.27
EBIT	-10.59	-12.64	-13.1	-14.25	-13.35	-8.27
Revenue as Reported	2.04	2.04	2.88	1.33	0.41	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.